Cargando…
Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non–small cell lung cancer
BACKGROUND: The Oncomine Dx Target Test Multi‐CDx System (ODxTT) is a next‐generation sequencing panel approved as a companion diagnostic for drugs targeted to corresponding gene alterations in non–small cell lung cancer. However, appropriate slide conditions for ODxTT have remained unclear. METHODS...
Autores principales: | Iwama, Eiji, Yamamoto, Hidetaka, Okubo, Fumihiko, Ijichi, Kayo, Ibusuki, Ritsu, Shiaraishi, Yoshimasa, Yoneshima, Yasuto, Tanaka, Kentaro, Oda, Yoshinao, Okamoto, Isamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423657/ https://www.ncbi.nlm.nih.gov/pubmed/37345344 http://dx.doi.org/10.1111/1759-7714.15014 |
Ejemplares similares
-
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L
por: Sakata, Shinya, et al.
Publicado: (2021) -
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer
por: Ibusuki, Ritsu, et al.
Publicado: (2022) -
Paired genetic analysis by next‐generation sequencing of lung cancer and associated idiopathic pulmonary fibrosis
por: Otsubo, Kohei, et al.
Publicado: (2020) -
Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease‐free survival in individuals with non‐small cell lung cancer
por: Ando, Nobuhisa, et al.
Publicado: (2020) -
Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade
por: Tanaka, Kentaro, et al.
Publicado: (2018)